Regenerative medicine company Exopharm Limited (ASX:EX1) announces first dosing has occurred in the PLEXOVAL Phase I study using exosomes...
Read More »Stem Cell Exomere Program announced by RoosterBio and Exopharm
RoosterBio Inc and Exopharm Pty Ltd today announce a formal heads of agreement under which they will work together on a Stem Cell Exomere Program, aimed at bringing high-grade therapeutic extracellular vesicles/exosomes derived from adult stem cells into clinical practice. ...
Read More »Exopharm company spun out to commercialise a completely new type of nano-drug for regenerative medicine
A private Australian biotechnology company called Exopharm has announced its investment to bring a completely new type of drug called exosomes into local clinical trials. Exopharm is founded and backed by Dr Ian Dixon, the Melbourne-based technology innovator behind an ...
Read More »